The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
The Texas Implementation of Medication Algorithms: Update to the Algorithms for Treatment of Bipolar I Disorder
Abstract
BACKGROUND: A panel consisting of academic psychiatrists and pharmacist administrators of the Texas Department of State Health Services (formerly Texas Department of Mental Health and Mental Retardation), community mental health physicians, advocates, and consumers met in May 2004 to review new evidence in the pharmacologic treatment of bipolar I disorder (BDI). The goal of the consensus conference was to update and revise the current treatment algorithm for BDI as part of the Texas Implementation of Medication Algorithms, a statewide quality assurance program for the treatment of major psychiatric illness. The guidelines for evaluating possible medications, the criteria for selection and ranking, and the updated algorithms are described. METHOD: Principles from previous consensus conferences were reviewed and amended. Medication algorithms for the acute treatment of hypomanic/manic or mixed and depressive episodes in BDI were developed after examining recent efficacy and safety and tolerability data. Recommendations for maintenance treatments were developed. RESULTS: The panel updated the 2 primary algorithms (hypomanic/manic/mixed and depressive) based on clinical evidence for efficacy, tolerability, and safety developed since 2000. Expert consensus was utilized where clinical evidence was limited. Prevention of new episodes or prophylaxis treatment recommendations were developed based on recent data from longer-term trials. Maintenance recommendations are provided as levels versus a specified staged algorithm, as for acute treatment, due to the relatively limited database to inform treatment. CONCLUSIONS: These algorithms for the treatment of BDI represent the recommendations based on the most recent evidence available. These recommendations are meant to provide a framework for clinical decision making, not to replace clinical judgment. As with any algorithm, treatment practices will evolve beyond the recommendations of this consensus conference as new evidence and additional medications become available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
(1976) · Medical Entomology and Zoology · Cited by 8,899
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
(1984) · The Lancet · doi:10.1016/s0140-6736(84)92810-1 · Cited by 2,925
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
Boehm, G., Racoosin, J. A., Laughren, T. P., & Katz, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2088-a · Cited by 1,204
Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0203 · Cited by 1,054
Self-citationTohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Self-citationCalabrese, J. R., Keck, P. E., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., Cutler, A. J., McCoy, R., Wilson, E., Mullen, J., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1351 · Cited by 883
Self-citationPhysical Health Monitoring of Patients With Schizophrenia
Marder, S. R., Essock, S. M., Miller, A. L., Buchanan, R. W., Casey, D. E., Davis, J. M., Kane, J. M., Lieberman, J. A., Schooler, N. R., Covell, N., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.8.1334 · Cited by 812
Colom, F., Vieta, E., Martínez-Arán, A., Reinares, M., Goikolea, J. M., Benabarre, A., Torrent, C., Comes, M., Corbella, B., Parramon, G., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.4.402 · Cited by 791
Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Study
Henderson, D. C., Cagliero, E., Gray, C., Nasrallah, R. A., Hayden, D. L., Schoenfeld, D. A., & Goff, D. C. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.975 · Cited by 701
Polycystic Ovaries and Hyperandrogenism in Women Taking Valproate for Epilepsy
Isojarvi, J., Laatikainen, T. J., Pakarinen, A. J., Juntunen, K., & Myllyla, V. V. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311043291904 · Cited by 688
Bowden, C. L. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.5.481 · Cited by 678
Self-citationBowden, C. L. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.4.392 · Cited by 658
Self-citationCalabrese, J. R., Bowden, C. L., Sachs, G., Yatham, L. N., Behnke, K., Mehtonen, O.-P., Montgomery, P., Ascher, J., Paska, W., Earl, N., et al. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0906 · Cited by 635
Self-citationMedical Comorbidity in Schizophrenia
Jeste, D. V., Gladsjo, J. A., Lindamer, L. A., & Lacro, J. P. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.3.413 · Cited by 624
Association of Diabetes Mellitus With Use of Atypical Neuroleptics in the Treatment of Schizophrenia
Sernyak, M. J., Leslie, D. L., Alarcon, R. D., Losonczy, M. F., & Rosenheck, R. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.4.561 · Cited by 623
Antipsychotic-induced weight gain: a review of the literature.
Allison, D. B., & Casey, D. E. (2001) · PubMed · Cited by 595
Perry, A., Tarrier, N., Morriss, R., McCarthy, E., & Limb, K. (1999) · BMJ · doi:10.1136/bmj.318.7177.149 · Cited by 586
Goodwin, G. M., Bowden, C. L., Calabrese, J. R., Grunze, H., Kasper, S., White, R., Greene, P., & Leadbetter, R. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0321 · Cited by 581 · cited 3×
“Lithium has multiple studies in support of its long-term efficacy and has an FDA indication for maintenance treatment of bipolar disorder.(16,103,107,128) As well, older studies support the use of lithium maintenance after depressive episodes.”
BackgroundResultSelf-citationAntidepressants for Bipolar Depression: A Systematic Review of Randomized, Controlled Trials
Gijsman, H. J., Geddes, J. R., Rendell, J. M., Nolen, W. A., & Goodwin, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.9.1537 · Cited by 563
Suicide Risk in Bipolar Disorder During Treatment With Lithium and Divalproex
Goodwin, F. K. (2003) · JAMA · doi:10.1001/jama.290.11.1467 · Cited by 531
Keck, P. E., Marcus, R., Tourkodimitris, S., Ali, M., Liebeskind, A., Saha, A., Ingenito, G., & Aripiprazole Study Group (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1651 · Cited by 501
Induction of Mania with Selective Serotonin Re-uptake Inhibitors and Tricyclic Antidepressants
Peet, M. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.4.549 · Cited by 474
Tohen, M., Chengappa, K. N. R., Suppes, T., Zarate, C. A., Calabrese, J. R., Bowden, C. L., Sachs, G. S., Kupfer, D. J., Baker, R. W., Risser, R. C., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.1.62 · Cited by 463
Self-citationValproatereatment of Acute Mania: A Placebo-Controlled
Pope, H. G. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810250064008 · Cited by 460
A Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood Disorders
Frye, M. A., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Speer, A. M., Osuch, E. A., Luckenbaugh, D. A., Corá-Locatelli, G., Leverich, G. S., & Post, R. M. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00004 · Cited by 446
Self-citationMiklowitz, D. J., Simoneau, T. L., George, E. L., Richards, J. A., Kalbag, A., Sachs-Ericsson, N., & Suddath, R. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00931-8 · Cited by 445
DELBELLO, M. P., SCHWIERS, M. L., ROSENBERG, H. L., & STRAKOWSKI, S. M. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200210000-00011 · Cited by 443
Sachs, G. S., Grossman, F., Ghaemi, S. N., Okamoto, A., & Bowden, C. L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1146 · Cited by 424 · cited 2×
“Two large, multicenter, randomized, double-blind, placebo-controlled add-on trials have been completed for risperidone.(58,59) A recent double-blind, placebo-controlled study supports that ziprasidone in combination with lithium reduces manic symptoms faster than lithium alone early in the course of treatment, althoug…”
BackgroundSelf-citationNemeroff, C. B., Evans, D. L., Gyulai, L., Sachs, G. S., Bowden, C. L., Gergel, I. P., Oakes, R., & Pitts, C. D. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.906 · Cited by 407
Self-citationElectroconvulsive therapy of acute manic episodes: a review of 50 years' experience
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.2.169 · Cited by 396
Mogens Dam (Chairman), R. E. (1989) · Epilepsy Research · doi:10.1016/0920-1211(89)90070-3 · Cited by 393
Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder
Suppes, T. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810360046007 · Cited by 392 · cited 3×
“The panel unanimously and strongly recommends that all patients with BDI receive continuous treatment with an antimanic agent.(15,16) For the purposes of the algorithm, antimanic agents are medications either that are approved by the U.”
BackgroundSelf-citationBowden, C. L., Grunze, H., Mullen, J., Brecher, M., Paulsson, B., Jones, M., Vågerö, M., & Svensson, K. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0116 · Cited by 376
Self-citationGoldberg, J. F., Burdick, K. E., & Endick, C. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.564 · Cited by 372
Keck, P. E., Versiani, M., Potkin, S., West, S. A., Giller, E., Ice, K., & the Ziprasidone in Mania Study Group (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.741 · Cited by 369
Weisler, R. H., Kalali, A. H., Ketter, T. A., & SPD417 Study Group (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0405 · Cited by 350
Self-citationPramipexole for bipolar II depression: a placebo-controlled proof of concept study
Zarate, C. A., Payne, J. L., Singh, J., Quiroz, J. A., Luckenbaugh, D. A., Denicoff, K. D., Charney, D. S., & Manji, H. K. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.03.013 · Cited by 347
Tohen, M., Ketter, T. A., Zarate, C. A., Suppes, T., Frye, M., Altshuler, L., Zajecka, J., Schuh, L. M., Risser, R. C., Brown, E., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1263 · Cited by 342
Self-citationRash in Multicenter Trials of Lamotrigine in Mood Disorders: Clinical Relevance and Management
Calabrese, J. R., Sullivan, J. R., Bowden, C. L., Suppes, T., Goldberg, J. F., Sachs, G. S., Shelton, M. D., Goodwin, F. K., Frye, M. A., & Kusumakar, V. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1110 · Cited by 334
Self-citationTohen, M., Chengappa, K. N. R., Suppes, T., Baker, R. W., Zarate, C. A., Bowden, C. L., Sachs, G. S., Kupfer, D. J., Ghaemi, S. N., Feldman, P. D., et al. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.4.337 · Cited by 326
Self-citationComparative Prophylactic Efficacy of Lithium, Carbamazepine, and the Combination in Bipolar Disorder
Denicoff, K. D., Smith-Jackson, E. E., Disney, E. R., Ali, S. O., Leverich, G. S., & Post, R. M. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n1102 · Cited by 311
Altshuler, L., Suppes, T., Black, D., Nolen, W. A., Keck, P. E., Frye, M. A., McElroy, S., Kupka, R., Grunze, H., Walden, J., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1252 · Cited by 287
Self-citationHirschfeld, R. M. A., Keck, P. E., Kramer, M., Karcher, K., Canuso, C., Eerdekens, M., & Grossman, F. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1057 · Cited by 273
Self-citationLower suicide risk with long‐term lithium treatment in major affective illness: a meta‐analysis
Tondo, L., Hennen, J., & Baldessarini, R. J. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00464.x · Cited by 269
Gilbert, D. A., Altshuler, K. Z., Rago, W. V., Shon, S. P., Crismon, M. L., Toprac, M. G., & Rush, A. J. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0702 · Cited by 264
Self-citationSachs, G., Chengappa, K., Suppes, T., Mullen, J., Brecher, M., Devine, N., & Sweitzer, D. (2004) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00115.x · Cited by 262
Self-citationYatham, L. N., Grossman, F., Augustyns, I., Vieta, E., & Ravindran, A. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.2.141 · Cited by 248
Electroconvulsive Treatment Compared With Lithium in the Management of Manic States
Small, J. G. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800320037004 · Cited by 246
A 12-Week, Double-blind Comparison of Olanzapine vs Haloperidol in the Treatment of Acute Mania
Tohen, M., Goldberg, J. F., Gonzalez-Pinto Arrillaga, A. M., Azorin, J. M., Vieta, E., Hardy-Bayle, M.-C., Lawson, W. B., Emsley, R. A., Zhang, F., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1218 · Cited by 229
Vieta, E., Martinez-Aran, A., Goikolea, J. M., Torrent, C., Colom, F., Benabarre, A., & Reinares, M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0607 · Cited by 227
McIntyre, R. S., Brecher, M., Paulsson, B., Huizar, K., & Mullen, J. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.02.006 · Cited by 227
Young, L. T., Joffe, R. T., Robb, J. C., MacQueen, G. M., Marriott, M., & Patelis-Siotis, I. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.124 · Cited by 211
Suppes, T., Webb, A., Paul, B., Carmody, T., Kraemer, H., & Rush, A. J. (2003) · Focus · doi:10.1176/foc.1.1.37 · Cited by 197
Self-citationSmulevich, A. B., Khanna, S., Eerdekens, M., Karcher, K., Kramer, M., & Grossman, F. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.06.003 · Cited by 192
Müller-Oerlinghausen, B., Retzow, A., Henn, F. A., Giedke, H., & Walden, J. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200004000-00012 · Cited by 170
Spectrum of Activity of Lamotrigine in Treatment-Refractory Bipolar Disorder
Calabrese, J. R., Bowden, C. L., McElroy, S. L., Cookson, J., Andersen, J., Keck, Jr., Rhodes, L., Bolden-Watson, C., Zhou, J., & Ascher, J. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1019 · Cited by 167
Self-citationMaintenance Efficacy of Divalproex in the Prevention of Bipolar Depression
Gyulai, L., Bowden, C. L., McElroy, S. L., Calabrese, J. R., Petty, F., Swann, A. C., Chou, J. C.-Y., Wassef, A., Risch, C. S., Hirschfeld, R. M. A., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300190 · Cited by 165
Self-citationDiagnosis and management of patients with bipolar II disorder.
Yatham, L. N. (2005) · PubMed · Cited by 163
Weisler, R. H., Keck, P. E., Swann, A. C., Cutler, A. J., Ketter, T. A., Kalali, A. H., & SPD417 Study Group (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0308 · Cited by 162
Self-citationPotkin, S. G., Keck, P. E., Segal, S., Ice, K., & English, P. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000169068.34322.70 · Cited by 159
Hyperglycemia associated with the use of atypical antipsychotics.
Lindenmayer, J., Nathan, A. M., & Smith, R. C. (2001) · PubMed · Cited by 155
Post, R. M., Leverich, G. S., Nolen, W. A., Kupka, R., Altshuler, L. L., Frye, M. A., Suppes, T. M., McElroy, S. L., Keck, P. E., Grunze, H., et al. (2003) · Bipolar Disorders · doi:10.1046/j.1399-5618.2003.00065.x · Cited by 154
Self-citationComparison of oxcarbazepine and carbamazepine: a double-blind study
Reinikainen, K. J., Keränen, T., Halonen, T., Komulainen, H., & Riekkinen, P. J. (1987) · Epilepsy Research · doi:10.1016/0920-1211(87)90003-9 · Cited by 143
Prophylactic Efficacy of Lithium Versus Carbamazepine in Treatment-Naive Bipolar Patients
Hartong, E. G. T. M., Moleman, P., Hoogduin, C. A. L., Broekman, T. G., Nolen, W. A., & LitCar Group (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0206 · Cited by 143
Bipolar Depression and Antidepressant-Induced Mania
Boerlin, H. L., Gitlin, M. J., Zoellner, L. A., & Hammen, C. L. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0706 · Cited by 142
The Texas Medication Algorithm Project (TMAP) Schizophrenia Algorithms
Miller, A. L., Chiles, J. A., Chiles, J. K., Crismon, M. L., Rush, A. J., & Shon, S. P. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1002 · Cited by 136
Self-citationMedication Treatment for the Severely and Persistently Mentally Ill
Rush, A. J., Rago, W. V., Crismon, M. L., Toprac, M. G., Shon, S. P., Suppes, T. M., Miller, A. L., Trivedi, M. H., Swann, A. C., Biggs, M. M., et al. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0503 · Cited by 129
Self-citationMelkersson, K. I., Hulting, A., & Brismar, K. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1112 · Cited by 125
Risperidone Safety and Efficacy in the Treatment of Bipolar and Schizoaffective Disorders
Vieta, E., Goikolea, J. M., Corbella, B., Benabarre, A., Reinares, M., MartÌnez, G., Fernandez, A., Colom, F., Martínez‐Arán, A., & Carla Torrent for the Group for the Study of Risperidone in Affective Disorders (GSRAD) (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1011 · Cited by 122
Report of the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder 2000
Suppes, T. M., Dennehy, E. B., Swann, A. C., Bowden, C. L., Calabrese, J. R., Hirschfeld, R. M. A., Keck, P. E., Sachs, G. S., Crismon, M. L., Toprac, M. G., et al. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0404 · Cited by 118
Self-citationReproductive function and risk for PCOS in women treated for bipolar disorder
Rasgon, N., Altshuler, L. L., Fairbanks, L. A., Elman, S., Bitran, J. A., Labarca, R., Saad, M. F., Kupka, R., Nolen, W. A., Frye, M. A., et al. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00201.x · Cited by 118
Self-citationCiapparelli, A., Dell’Osso, L., Tundo, A., Pini, S., Chiavacci, M. C., Sacco, I. D., & Cassano, G. B. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n07a09 · Cited by 107
Psychoeducational and cognitive-behavioral strategies in the management of bipolar disorder
Otto, M. W., Reilly-Harrington, N. A., & Sachs, G. S. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00460-8 · Cited by 102
Self-citation(2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)81278-3 · Cited by 96
Gilbert, D. A., Altshuler, K. Z., Rago, W. V., Shon, S. P., Crismon, M. L., Toprac, M. G., & Rush, A. J. (1998) · PubMed · Cited by 94
Self-citationContinuation and Maintenance ECT in Treatment-Resistant Bipolar Disorder
Vaidya, N. A., Mahableshwarkar, A. R., & Shahid, R. (2003) · Journal of Ect · doi:10.1097/00124509-200303000-00003 · Cited by 90
McConville, B. J., Carrero, L., Sweitzer, D. E., Potter, L. S., Chaney, R. O., Foster, K. D., Sorter, M. T., Friedman, L., & Browne, K. (2003) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454603321666216 · Cited by 83
Long-term risperidone treatment in bipolar disorder: 6-month follow up*
Ghaemi, S. N., & Sachs, G. S. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199711000-00006 · Cited by 76
Self-citationOxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode
Benedetti, A. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00407-x · Cited by 74
Controlled trials in bipolar I depression: focus on switch rates and efficacy
Calabrese, J. R., RAPPORT, D. J., Kimmel, S. E., & Shelton, M. D. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00023-1 · Cited by 73
Self-citationOxcarbazepine Treatment of Bipolar Disorder
Ghaemi, S. N., Berv, D. A., Klugman, J., Rosenquist, K. J., & Hsu, D. J. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0813 · Cited by 70
Quetiapine Alone and Added to a Mood Stabilizer for Serious Mood Disorders
Sajatovic, M., Brescan, D. W., Perez, D. E., DiGiovanni, S. K., Hattab, H., Belton, J., & Bingham, C. R. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0911 · Cited by 68
Lamotrigine for the treatment of bipolar disorder: a clinical case series
Suppes, T. M., Brown, E. S., McElroy, S. L., Keck, P. E., Nolen, W. A., Kupka, R., Frye, M. A., Denicoff, K. D., Altshuler, L. L., Leverich, G. S., et al. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00077-9 · Cited by 64
Self-citationRelationship of Atypical Antipsychotics with Development of Diabetes Mellitus
Citrome, L., & Jaffe, A. B. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d142 · Cited by 64
A 52-Week, Open-Label Continuation Study of Lamotrigine in the Treatment of Bipolar Depression
McElroy, S. L., Zarate, C. A., Cookson, J., Suppes, T. M., Huffman, R., Greene, P., & Ascher, J. A. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0210 · Cited by 63
Self-citationResponse to ECT in major depression: are there differences between unipolar and bipolar depression?
Grunhaus, L. J., Schreiber, S., Dolberg, O. T., Hirschmann, S., & Dannon, P. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.4.s1.40.x · Cited by 63
Ketter, T. A., Kalali, A. H., Weisler, R. H., & SPD417 Study Group (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0511 · Cited by 61
Self-citationSuppes, T. M., Swann, A. C., Dennehy, E. B., Habermacher, E. D., Mason, M., Crismon, M. L., Toprac, M. G., Rush, A. J., Shon, S. P., & Altshuler, K. Z. (2001) · PubMed · Cited by 58
Self-citationCitalopram as Adjunctive Therapy in Bipolar Depression
Kupfer, D. J., Chengappa, K. N. R., Gelenberg, A. J., Hirschfeld, R. M. A., Goldberg, J. F., Sachs, G. S., Grochocinski, V. J., Houck, P. R., & Kolar, A. B. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1212 · Cited by 58
Self-citationAltamura, A. C. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00075-7 · Cited by 54
Advances in the pharmacologic treatment of bipolar depression
Keck, P. E., Nelson, E. B., & McElroy, S. L. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01741-9 · Cited by 49
Treatment of Bipolar Depression, a Review of the Literature and a Suggestion for an Algorithm
Nolen, W. A., & Bloemkolk, D. (2000) · Neuropsychobiology · doi:10.1159/000054845 · Cited by 49
Weight Gain During Treatment of Bipolar I Patients With Olanzapine
Hennen, J. A., Perlis, R. H., Sachs, G. S., Tohen, M. F., & Baldessarini, R. J. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1214 · Cited by 48
Self-citationUnderstanding the new and evolving profile of adverse drug effects in schizophrenia
Wirshing, D. A., Pierre, J. M., Erhart, S. M., & Boyd, J. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00035-7 · Cited by 47
Andersen, U. A., Andersen, M. T., Rosholm, J.-U., & Gram, L. F. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00191.x · Cited by 45
Risperidone in acute and continuation treatment of mania
Yatham, L. N., Binder, C. E., Riccardelli, R., Leblanc, J., Connolly, M. B., & Kusumakar, V. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200307000-00005 · Cited by 43
Risperidone in Combination With Mood Stabilizers
Bowden, C. L., Myers, J. E., Grossman, F., & Xie, Y. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0518 · Cited by 42
Self-citationKleindienst, N., & Greil, W. (2002) · Psychological Medicine · doi:10.1017/s0033291702005251 · Cited by 40
Maintenance ECT for Recurrent Medication-refractory Mania
Tsao, C. I. P., Jain, S., Gibson, R. H., Guedet, P. J., & Lehrmann, J. A. (2004) · Journal of Ect · doi:10.1097/00124509-200406000-00008 · Cited by 37
Evidence-based long-term treatment of bipolar II disorder.
Suppes, T. M., & Dennehy, E. B. (2002) · PubMed · Cited by 29
Self-citationUse of quetiapine in bipolar disorder: a case series with prospective evaluation
Suppes, T. M., McElroy, S. L., Keck, P. E., Altshuler, L. L., Frye, M. A., Grunze, H., Leverich, G. S., Nolen, W. A., Chisholm, K., Dennehy, E. B., et al. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200405000-00010 · Cited by 23
Self-citationEvans, A. R., Tohen, M. F., Marneros, A., Bowden, C. L., Greil, W., Koukopoulis, A., Belmaker, R. H., Jacobs, T. G., Baker, R., Williamson, D., et al. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)91802-5 · Cited by 23
Self-citationOxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders
Raja, M., & Azzoni, A. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003754 · Cited by 16
Khanna, S., Vieta, E., Lyons, B., Grossman, F., & Kramer, M. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)92033-5 · Cited by 13
Switch rate on venlafaxine compared with bupropion and sertraline
Post, R. M., Altshuler, L., Leverich, G. S., Frye, M., Nolen, W. A., Kupka, R., Suppes, T. M., McElroy, S. L., Pe, K., Denicoff, K. D., et al. (2004) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2
Self-citationEfficacy of Divalproex vs Lithium and Placebo in the Treatment of Mania
Bowden, C. L. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510360044034 · Cited by 1
Self-citation
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., Gyulai, L., Friedman, E. S., Bowden, C. L., Fossey, M. D., Ostacher, M. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064135 · Cited by 937
Self-citationThase, M. E., Macfadden, W., Weisler, R. H., Chang, W., Paulsson, B., Khan, A., & Calabrese, J. R. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000248603.76231.b7 · Cited by 559
Self-citationIntroduction: Methods, Commentary, and Summary
ALLEN, M. H., CURRIER, G. W., CARPENTER, D., ROSS, R. W., & DOCHERTY, J. P. (2005) · Journal of Psychiatric Practice · doi:10.1097/00131746-200511001-00002 · Cited by 267
Nierenberg, A. A., Ostacher, M. J., Calabrese, J. R., Ketter, T. A., Marangell, L. B., Miklowitz, D. J., Miyahara, S., Bauer, M. S., Thase, M. E., Wisniewski, S. R., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.210 · Cited by 257
Self-citation
Metadata
- Authors
- Suppes, T., Dennehy, E. B., Hirschfeld, R. M. A., Altshuler, L. L., Bowden, C. L., Calabrese, J. R., Crismon, M. L., Ketter, T. A., Sachs, G. S., Swann, A. C., & Disorder, T. C. C. P. O. M. T. O. B.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2005-07-15
- Volume
- 66
- Issue
- 07
- Pages
- 870-886
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2170351165
- Cited by
- 330
- References
- 111
- FWCI
- 18.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.